Contract facts
UnrestrictedNo full NAICS 541714 intel page yet. Browse NAICS intelligence
BAA Contract- FY26C2AP9 Advanced CMC Index and Intelligence Platform for Drug Quality Control, Shortage Prediction, and… is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by National Institute for Pharmaceutical Technology & Education Inc. Estimated value $635K ($635K obligated). Current period of performance ends Sep 29, 2027. Last award drew 1 bidder. Place of performance: MINNEAPOLIS MN. Related solicitation FDABAA-26-00123.
Baa contract- fy26c2ap9 advanced cmc index and intelligence platform for drug quality control, shortage prediction, and strategic reshoring
Recompete timing
PublicCurrent PoP ends Sep 29, 2027 (347 days remaining). Agencies typically plan 12–18 months ahead — at 11.4 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75F40126C00069? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNational Institute for Pharmaceutical Technology & Education Inc — $1.5M obligated across 3 awards (firm-wide, all agencies).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40126C00069?
75F40126C00069 (BAA contract- fy26c2ap9 advanced CMC index) is a Fda Office Of Acq Grant Svcs award with a potential value of $635K, currently held by National Institute for Pharmaceutical Technology & Education Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40126C00069?
Fda Office Of Acq Grant Svcs awarded 75F40126C00069 to National Institute for Pharmaceutical Technology & Education Inc (potential $635K).
Who is the incumbent on 75F40126C00069?
National Institute for Pharmaceutical Technology & Education Inc is the incumbent with $1.5M across 3 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2027.
When does National Institute for Pharmaceutical Technology & Education Inc’s 75F40126C00069 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75F40126C00069? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.